Nxera Pharma Co., Ltd. (4565.T) JPX
Currency In JPY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In JPY
| Market Cap | 74.66B |
| Enterprise Value | 111.67B |
| P/E Ratio | -8.99 |
| PEG Ratio | 0.09 |
| Price/Sales Ratio | 2.66 |
| Price/Book Ratio | 1.41 |
| Enterprise/Revenue | 3.96 |
| Enterprise/EBITDA | 63.54 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.29 |
| Operating Margin | -0.07 |
| Return On Assets | -0.07 |
| Return On Equity | -0.16 |
| Revenue | 29.62B |
| Revenue/Share | 378.22 |
| Gross Profit | 21.42B |
| EBITDA | -3.91B |
| Net Income | -12.53B |
| Diluted EPS | -138.8 |
| Total Cash | 11.6B |
| Total Cash/Share | 128.15 |
| Total Debt | 55.83B |
| Total Debt/Equity | 0.88 |
| Current Ratio | 2.61 |
| Book Value Per Share | 703.75 |
| 52-Week Change | 12.44 |
| 52-Week High | 1,247 |
| 52-Week Low | 723 |
| Moving Average 50 Days | 1,034.22 |
| Moving Average 200 Days | 931.5 |
| Average Volume | 1.06M |
| Shares Outstanding | 91.73M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 4:1 |
| Last Split Date | June 27, 2018 |